Organisation paid for research Program year 2025 Source: CMS Open Payments

Advanced Research Consultants, Inc

Neither a doctor nor a teaching hospital

Research payments

$407,734

12 payments

Through program year 2025, Advanced Research Consultants, Inc is reported as receiving $407,734 in research payments, across 12 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$37,470	4
2022	Research	$83,720	4
2021	Research	$190,166	2
2020	Research	$96,378	2

Breakdown

Who paid Research payments · program years 2020–2025

Biogen, Inc. $344,145 4 payments
Novo Nordisk AS $37,470 4 payments
Avanir Pharmaceuticals, Inc. $26,119 4 payments

Studies the money was for Research payments · program years 2020–2025

A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 $269,634 2 payments
Phase 3b Open-Label, Multicenter, Safety Study of BIIB037 (aducanumab) in Subjects with Alzheimer's disease Who Had Previously Participated in the Aducanumab Studies221AD103, 221AD301, 221AD302 and 221AD205 $69,701 1 payment
Nn6535-4725 $37,470 4 payments
20-Avp-786-306 $26,119 4 payments
221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease $4,810 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.